Clinical Trials Directory

Trials / Completed

CompletedNCT06640504

Serum Albumin Ratios Can Improve Sepsis Mortality Prediction

Serum Albumin Ratios Correct the Ability of Traditional Biomarkers to Predict Mortality of Sepsis Patients Admitted to Surgical ICU

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Benha University · Academic / Other
Sex
All
Age
12 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Sepsis remains a leading cause of mortality in hospitalized patients, despite advancements in critical care. Existing clinical scores for predicting sepsis outcomes often lack generalizability and complexity, hindering accurate risk assessment and timely intervention. This study aimed to evaluate the prognostic performance of serum albumin ratios to C-reactive protein (CRP), procalcitonin (PCT), and lactate in predicting 28-day morbidities and mortality in sepsis patients admitted to surgical ICUs. By incorporating these albumin ratios into clinical decision-making, we hypothesized that clinicians could more accurately identify patients at high risk of adverse outcomes and tailor treatment strategies accordingly.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTserum albuminSerum albumin ratios were calculated as the ratio between the estimated blood lactate, and serum levels of CRP and PCT divided by the estimated serum albumin level to get the lactate-to-albumin ratio (LAR), CRP-to-albumin ratio (CAR) and procalcitonin (PCT)-to-albumin ratio (PAR).
DIAGNOSTIC_TESTC-Reactive ProteinThe serum levels of C-reactive protein (CRP) are divided by the estimated serum albumin level to get the CRP-to-albumin ratio (CAR).
DIAGNOSTIC_TESTSerum procalcitoninThe serum levels of procalcitonin (PCT) are divided by the estimated serum albumin level to get the PCT-to-albumin ratio (PAR).
DRUGBlood LactateThe serum levels of blood lactate are divided by the estimated serum albumin level to get the lactate-to-albumin ratio (LAR).

Timeline

Start date
2024-09-30
Primary completion
2024-11-30
Completion
2024-12-30
First posted
2024-10-15
Last updated
2025-11-28

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06640504. Inclusion in this directory is not an endorsement.